Product Information

LEVOTHYROXINE 50 MCG TABLET is a generic product labeled by Lannett Company Inc., priced at $0.0401 per EA under NDC 00527328143. Its NADAC has been published 326 times since Aug 19, 2020.

FDA first approved this application on Mar 1, 2002. Its Orange Book therapeutic-equivalence code is AB1,AB2,AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVOTHYROXINE 50 MCG TABLET

Levothyroxine Sodium
$0.0401per EA

Strength

50 ug/1

NDC

00527328143

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

LEVOTHYROXINE SODIUM

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021342

FDA Approved

3/1/2002

TE Code

AB1,AB2,AB3

On Market Since

8/3/2020

Pharmacological Classes

Thyroxine
l-Thyroxine

Price Statistics

The NADAC for LEVOTHYROXINE 50 MCG TABLET has been published 326 times since Aug 19, 2020, and over the history we have for it it has declined 83.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0401 per EA
All-time high$0.2472 (Sep 16, 2020)
All-time low$0.0401 (Oct 21, 2026)
52-week high$0.0524
52-week low$0.0401
Median price$0.0684
Average price$0.1054
Largest weekly change+35.8% (Jun 19, 2024)
Weeks tracked326
Tracking sinceAug 19, 2020

Price History

1W

0.0%

1M

-1.6%

3M

-1.4%

6M

-13.3%

1Y

-23.3%

3Y

-33.3%

5Y

-77.0%

All

-83.8%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LEVOTHYROXINE 50 MCG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVOTHYROXINE 50 MCG TABLET, manufactured by Lannett Company Inc., is $0.0401 per EA (NDC 00527328143), effective Nov 11, 2026.

How has the price of LEVOTHYROXINE 50 MCG TABLET changed over time?

Over the history we have for it, the NADAC for LEVOTHYROXINE 50 MCG TABLET has declined 83.8%. It has been tracked across 326 weekly CMS publications since Aug 19, 2020.

What are the highest and lowest recorded NADAC prices for LEVOTHYROXINE 50 MCG TABLET?

Since Aug 19, 2020, the NADAC for LEVOTHYROXINE 50 MCG TABLET has ranged from a low of $0.0401 (Oct 21, 2026) to a high of $0.2472 (Sep 16, 2020), with a median of $0.0684 per EA.

Are there cheaper alternatives to LEVOTHYROXINE 50 MCG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEVOTHYROXINE 50 MCG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures LEVOTHYROXINE 50 MCG TABLET?

LEVOTHYROXINE 50 MCG TABLET (NDC 00527328143) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.